291 related articles for article (PubMed ID: 18318428)
1. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Cancer; 2008 May; 112(9):1964-73. PubMed ID: 18318428
[TBL] [Abstract][Full Text] [Related]
2. Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.
Rebbeck TR; Troxel AB; Wang Y; Walker AH; Panossian S; Gallagher S; Shatalova EG; Blanchard R; Bunin G; DeMichele A; Rubin SC; Baumgarten M; Berlin M; Schinnar R; Berlin JA; Strom BL
J Natl Cancer Inst; 2006 Sep; 98(18):1311-20. PubMed ID: 16985250
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia.
Gulyaeva LF; Mikhailova ON; PustyInyak VO; Kim IV; Gerasimov AV; Krasilnikov SE; Filipenko ML; Pechkovsky EV
Adv Exp Med Biol; 2008; 617():359-66. PubMed ID: 18497059
[TBL] [Abstract][Full Text] [Related]
4. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
5. Adenomyosis: genetics of estrogen metabolism.
Artymuk N; Zotova O; Gulyaeva L
Horm Mol Biol Clin Investig; 2019 Mar; 37(2):. PubMed ID: 30878995
[TBL] [Abstract][Full Text] [Related]
6. CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.
O'Mara TA; Ferguson K; Fahey P; Marquart L; Yang HP; Lissowska J; Chanock S; Garcia-Closas M; Thompson DJ; Healey CS; Dunning AM; Easton DF; ; Webb PM; Spurdle AB
Twin Res Hum Genet; 2011 Aug; 14(4):328-32. PubMed ID: 21787115
[TBL] [Abstract][Full Text] [Related]
7. Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk.
Mikhailova ON; Gulyaeva LF; Prudnikov AV; Gerasimov AV; Krasilnikov SE
Pharmacogenomics J; 2006; 6(3):189-93. PubMed ID: 16402077
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer.
Khvostova EP; Pustylnyak VO; Gulyaeva LF
Genet Test Mol Biomarkers; 2012 Mar; 16(3):167-73. PubMed ID: 21977969
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in CYP1A1, CYP2D6, UGT1A6, UGT1A7, and SULT1A1 genes and correlation with benzene exposure in a Chinese occupational population.
Gu SY; Zhang ZB; Wan JX; Jin XP; Xia ZL
J Toxicol Environ Health A; 2007 Jun; 70(11):916-24. PubMed ID: 17479406
[TBL] [Abstract][Full Text] [Related]
11. Association of testicular germ cell tumor with polymorphisms in estrogen receptor and steroid metabolism genes.
Ferlin A; Ganz F; Pengo M; Selice R; Frigo AC; Foresta C
Endocr Relat Cancer; 2010 Mar; 17(1):17-25. PubMed ID: 19776291
[TBL] [Abstract][Full Text] [Related]
12. Association of CYP1A1 gene variants rs4646903 (T>C) and rs1048943 (A>G) with cervical cancer in a North Indian population.
Abbas M; Srivastava K; Imran M; Banerjee M
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():68-74. PubMed ID: 24657182
[TBL] [Abstract][Full Text] [Related]
13. Interactions between genetic polymorphism of cytochrome P450-1B1, sulfotransferase 1A1, catechol-o-methyltransferase and tobacco exposure in breast cancer risk.
Saintot M; Malaveille C; Hautefeuille A; Gerber M
Int J Cancer; 2003 Nov; 107(4):652-7. PubMed ID: 14520706
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphisms of the Human Cytochrome P450 1A1 (CYP1A1) and Cervical Cancer Susceptibility among Northeast Thai Women.
Wongpratate M; Ishida W; Phuthong S; Natphopsuk S; Ishida T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):243-248. PubMed ID: 31983191
[TBL] [Abstract][Full Text] [Related]
15. Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer.
Ihsan R; Chauhan PS; Mishra AK; Yadav DS; Kaushal M; Sharma JD; Zomawia E; Verma Y; Kapur S; Saxena S
PLoS One; 2011; 6(12):e29431. PubMed ID: 22206016
[TBL] [Abstract][Full Text] [Related]
16. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
17. COMT polymorphisms affecting protein expression are risk factors for endometrial cancer.
Hirata H; Hinoda Y; Okayama N; Suehiro Y; Kawamoto K; Kikuno N; Rabban JT; Chen LM; Dahiya R
Mol Carcinog; 2008 Oct; 47(10):768-74. PubMed ID: 18324659
[TBL] [Abstract][Full Text] [Related]
18. Genotypes of CYP1A1, SULT1A1 and SULT1A2 and risk of squamous cell carcinoma of esophagus: outcome of a case-control study from Kashmir, India.
Shah IA; Bhat GA; Mehta P; Lone MM; Dar NA
Dis Esophagus; 2016 Nov; 29(8):937-943. PubMed ID: 26455829
[TBL] [Abstract][Full Text] [Related]
19. Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1.
Ung D; Nagar S
Drug Metab Dispos; 2007 May; 35(5):740-6. PubMed ID: 17293380
[TBL] [Abstract][Full Text] [Related]
20. Possible risk modification by polymorphisms of estrogen metabolizing genes in familial breast cancer susceptibility in an Indian population.
Syamala VS; Syamala V; Sheeja VR; Kuttan R; Balakrishnan R; Ankathil R
Cancer Invest; 2010 Mar; 28(3):304-11. PubMed ID: 19863350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]